Beta-sitosterol upregulated paraoxonase-1 via peroxisome proliferator-activated receptor-γ in irradiated rats.

about

Beta-sitosterol upregulated paraoxonase-1 via peroxisome proliferator-activated receptor-γ in irradiated rats.

Item

http://www.wikidata.org/entity/Q51146823

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Beta-sitosterol upregulated pa ...... receptor-γ in irradiated rats.

@en

Beta-sitosterol upregulated pa ...... receptor-γ in irradiated rats.

@nl

type

Item

label

Beta-sitosterol upregulated pa ...... receptor-γ in irradiated rats.

@en

Beta-sitosterol upregulated pa ...... receptor-γ in irradiated rats.

@nl

prefLabel

Beta-sitosterol upregulated pa ...... receptor-γ in irradiated rats.

@en

Beta-sitosterol upregulated pa ...... receptor-γ in irradiated rats.

@nl

P1476

Beta-sitosterol upregulated pa ...... receptor-γ in irradiated rats.

@en

P2093

Enas Mahmoud Moustafa

http://www.w3.org/2001/XMLSchema#string

P2860

Plant sterols: factors affecting their efficacy and safety as functional food ingredients

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders

Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat

Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat.

Effect of Increasing Doses of γ-Radiation on Bone Marrow Stromal Cells Grown on Smooth and Rough Titanium Surfaces.

Beta-Sitosterol: A Promising but Orphan Nutraceutical to Fight Against Cancer.

Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.

PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways.

Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?

P304

661-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/CJPP-2016-0397

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Noura M Thabet

P577

2017-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28177669

http://www.w3.org/2001/XMLSchema#string